期刊文献+

四种恶性风险指数对卵巢肿瘤良恶性鉴别的诊断价值 被引量:2

Diagnostic value of four types of risk of malignancy index in distinguishing benign and malignant ovarian tumors
原文传递
导出
摘要 目的评估4种恶性风险指数(RMI)对鉴别卵巢肿瘤良恶性的诊断价值。方法回顾性分析2017年10月至2018年10月在常州市第二人民医院接受治疗的200例卵巢肿瘤患者的术前癌抗原125(CA125)水平、绝经状态、超声分数、肿瘤大小以及术后病理等资料,采用不同的计算方法(RMI1、RMI2、RMI3、RMI4)计算卵巢肿瘤的RMI,并进行良恶性判定,结果与病理对照,评价在不同病理组织类型和临床分期的诊断价值,通过ROC曲线比较4种RMI与单项指标诊断效能的高低,以及各项的阳性预测值、阴性预测值、特异度和敏感度。采用Cochran's Q检验比较RMI1、RMI2、RMI3、RMI4四种方法的异同,Dunn's检验(经Bonferroni法校正)进行4种指数的两两比较。结果RMI1、RMI2、RMI3、RMI4的ROC曲线下面积分别为0.859、0.872、0.866、0.878。根据ROC曲线分析,RMI1、RMI2、RMI3的界值为100,RMI4的界值为200时,其敏感度分别为77.5%、82.6%、80.0%、82.5%,特异度分别为94.4%、91.9%、93.1%、93.1%,阳性预测值分别为77.5%、71.7%、74.4%、75.0%,高于原始界值的阳性预测值。4种RMI诊断效能比较差异具有统计学意义(χ^2=8.333,P=0.04),进行两两比较,发现RMI1与RMI2两种方法之间差异具有统计学意义(P=0.028)。RMI对卵巢恶性上皮性肿瘤的诊断率较高(71%、77%、71%、74%),其中RMI2的诊断率比其他3种RMI高;RMI对卵巢非上皮性肿瘤的诊断率较低(均为40%)。在卵巢恶性肿瘤中,对I期病变及交界性肿瘤的诊断率低。结论4种RMI对卵巢肿瘤的良恶性诊断均有较高的特异度和阳性预测值,但对非上皮性肿瘤、交界性肿瘤、卵巢肿瘤早期患者敏感度较低,仍需进一步改良。 Objective To assess the value of four kinds of risk of malignancy index(RMI)in the differential diagnosis of benign and malignant ovarian tumors.Methods We retrospectively analyzed the preoperative CA125 levels,menopausal status,ultrasound score,tumor size,and postoperative pathological data of 200 patients with ovarian tumors who were treated at Changzhou Second People's Hospital from October 2017 to October 2018.We used different calculation methods(RMI1,RMI2,RMI3,and RMI4)to calculate the RMI for distinguishing benign and malignant ovarian tumors,and the results were compared with pathology to evaluate their diagnostic value among different pathological tissue types and clinical stages.ROC curve analysis was performed to compare their diagnostic power with individual indicators and calculate their positive predictive value,negative predictive value,specificity,and sensitivity.The Cochran's Q test was used to compare the similarities and differences of the four methods(RMI1,RMI2,RMI3,and RMI4),and the Dunn's test(corrected by Bonferroni method)was used for pairwise comparison of the four methods.Results The areas under the ROC curves of RMI1,RMI2,RMI3,and RMI4 were 0.859,0.872,0.866,0.878,respectively.According to the ROC curve analysis,when the cutoff values of RMI1,RMI2,and RMI3 were all 100,and that of RMI4 was 200,the sensitivities were 77.5%,82.6%,80.0%,and 82.5%,and the specificities were 94.4%,91.9%,93.1%,and 93.1%,respectively.The positive predictive values were 77.5%,71.7%,74.4%,and 75.0%,respectively,which were higher than those of the original threshold.There were significant differences among the four RMI methods(χ^2=8.333,P=0.04).After pairwise comparison,it was found that only RMI1 and RMI2 had a significant difference(P=0.028).RMI had a higher diagnostic rate for malignant epithelial ovarian tumors(71%,77%,71%,and 74%),and RMI2 had a higher diagnostic rate than the other three RMIs.However,RMI had a lower diagnostic rate for non-epithelial ovarian tumors(40%each).Among ovarian malignant tumors,the diagnosis rate for stage I lesions and borderline tumors was low.Conclusion The four RMIs have high specificity and positive predictive value for the diagnosis of benign and malignant ovarian tumors,but the sensitivity to non-epithelial tumors,borderline tumors,and early-stage ovarian tumors is low,and further improvement is needed.
作者 马士红 李晓琴 施燕芸 Ma Shihong;Li Xiaoqin;Shi Yanyun(Department of Ultrasound,Changzhou Second People's Hospital Affiliated to Nanjing Medical University,Changzhou 213000,China)
出处 《中华医学超声杂志(电子版)》 CSCD 北大核心 2020年第11期1108-1113,共6页 Chinese Journal of Medical Ultrasound(Electronic Edition)
关键词 卵巢肿瘤 癌抗原125 超声 恶性风险指数 Ovarian neoplasms Cancer antigen 125 Ultrasound Risk of malignancy index
  • 相关文献

参考文献4

二级参考文献26

  • 1[1]Gillis CR, Hole DJ, Still RM, et al. Medical edit, cancer registration, and survival in ovarian cancer[J]. Lancet,1991,337:611-612
  • 2[2]Sassone AM, Timor-Tritsch IE, Artner A, et al. Transvaginal sonogr aphic c haracterization of ovarian disease: Evaluation of a new scoring system to predic t ovarian malignancy[J].Obstet Gynecol,1991,78:70-76
  • 3[3]Jacobs I, Oram D, Fairbanks J, et al. A risk of malignancy index incorporating CA125, ultrasou nd and menopausal status for the accurate preoperative diagnosis of ovarian canc er[J].Br J Obstet Gynecol,1990,97:922-929
  • 4[4]Tingulstad S, Hagen B, Skj eldestad FE, et al. Evaluation of a risk of malignancy index based on serum CA125, ultrasound and menopausal status in the pre-operative diagnosis of pelvicmass es[J].Br J Obstet Gynecol,1996, 103:826-831
  • 5[5]Patsner B, Mann WJ. The v alue of preoperative serum CA125levels in patients with a pelvic mass findings [J] .Am J Obstet Gynecol,1988,159:873-876
  • 6[6]Davies AP,Jacobs I, Woolas R, et al . The adnexal mass:Benign or malignant?Evaluation of a risk of malignancy index findings[J].Br J Obstet Gynecol,1993,100:927-931
  • 7[7]Morga nte G, Marca AL, Ditt o A,et al. Comparison of two malignancy risk indices based on serum CA125,ultras ound score and menopausal status in the diagnosis of ovarian masses[J]. Br J Obstet Gynecol,1999,106:524-527
  • 8[1]Jacobs I, Oram D, Fairbanks J, et al. A risk of malignancy index incorporation CA125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer [J]. Br J Obstet Gynecol, 1990, 97(10): 922~929
  • 9[2]Tingulstad S, Hagen B, Skjeldestad FE, et al. Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses[J]. BrJ Obstet Gynecol, 1996, 103(8): 826~831
  • 10[3]Tingulstad S, Hagen B, Skjeldestad FE, et al. The risk-of-malignancy index to evaluate potential ovarian cancer in local hospital [J]. Obstet Gynaecol, 1999, 93(3): 448~451

共引文献24

同被引文献19

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部